S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|CF Industries, Yara call off merger talks (2014/10/17)|
|Vertex Announces Upcoming Presentations of Data at North American Cystic Fibrosis Conference - October 9 to 11, 2014|
|Vertex Reviews Recent Progress and Announces Upcoming Milestones in the Development of Multiple Combinations of Medicines that Target the Underlying Cause of Cystic Fibrosis|
|FDA Advisory Committee Recommends Approval of KALYDECO® (ivacaftor) for Use in People with Cystic Fibrosis Ages 6 and Older Who Have the R117H Mutation|
|CF Industries Holdings, Inc. Reports Third Quarter Net Earnings of $130.9 Million (2014/11/5)|
|Vertex Submits Applications in the U.S. and Europe for Approval of Lumacaftor in Combination with Ivacaftor for People with Cystic Fibrosis Who Have Two Copies of the F508del Mutation|
|Theresa E. Wagler Elected to Board of Directors of CF Industries Holdings, Inc. (2014/10/27)|
|CF Industries Confirms Merger of Equals Discussions With Yara International|
|CF Industries Announces Termination of Merger Discussions with Yara International (2014/10/16)|
|CF Industries Holdings, Inc. Announces Dates for Third Quarter 2014 Results and Conference Call (2014/10/24)|
Click above to view more mutual fund data and stats for 8229 - CFS Corporation.